178 related articles for article (PubMed ID: 2784682)
1. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.
Arner EC; Pratta MA
Arthritis Rheum; 1989 Mar; 32(3):288-97. PubMed ID: 2784682
[TBL] [Abstract][Full Text] [Related]
2. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
3. Independent effects of interleukin 1 on proteoglycan synthesis and proteoglycan breakdown of bovine articular cartilage in vitro.
Neidel J; Zeidler U
Agents Actions; 1993 May; 39(1-2):82-90. PubMed ID: 8285145
[TBL] [Abstract][Full Text] [Related]
4. Modulation of interleukin-1-induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C.
Arner EC; Pratta MA
Arthritis Rheum; 1991 Aug; 34(8):1006-13. PubMed ID: 1859477
[TBL] [Abstract][Full Text] [Related]
5. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
Rainsford KD; Ying C; Smith FC
J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
[TBL] [Abstract][Full Text] [Related]
6. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
Mastbergen SC; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2008 Jan; 67(1):52-8. PubMed ID: 17485421
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-1-beta and tumor necrosis factor-alpha on cartilage proteoglycan metabolism in vitro.
Pratta MA; Di Meo TM; Ruhl DM; Arner EC
Agents Actions; 1989 Jun; 27(3-4):250-3. PubMed ID: 2801305
[TBL] [Abstract][Full Text] [Related]
9. Effects of equine recombinant interleukin-1alpha and interleukin-1beta on proteoglycan metabolism and prostaglandin E2 synthesis in equine articular cartilage explants.
Takafuji VA; McIlwraith CW; Howard RD
Am J Vet Res; 2002 Apr; 63(4):551-8. PubMed ID: 11939318
[TBL] [Abstract][Full Text] [Related]
10. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro.
Henrotin YE; Labasse AH; Simonis PE; Zheng SX; Deby GP; Famaey JP; Crielaard JM; Reginster JY
Clin Exp Rheumatol; 1999; 17(2):151-60. PubMed ID: 10342040
[TBL] [Abstract][Full Text] [Related]
11. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta.
Huch K; Wilbrink B; Flechtenmacher J; Koepp HE; Aydelotte MB; Sampath TK; Kuettner KE; Mollenhauer J; Thonar EJ
Arthritis Rheum; 1997 Dec; 40(12):2157-61. PubMed ID: 9416852
[TBL] [Abstract][Full Text] [Related]
13. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants.
Nietfeld JJ; Wilbrink B; Den Otter W; Huber J; Huber-Bruning O
J Rheumatol; 1990 Jun; 17(6):818-26. PubMed ID: 2388205
[TBL] [Abstract][Full Text] [Related]
14. Effects of anti-inflammatory drugs and agents that modify intracellular transduction signals or metabolic activities in inflammatory cells on interleukin-1 induced cartilage proteoglycan resorption in vitro.
Rainsford KD
Pharmacol Res; 1992; 25(4):335-46. PubMed ID: 1329061
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation.
Arner EC; Darnell LR; Pratta MA; Newton RC; Ackerman NR; Galbraith W
Agents Actions; 1987 Aug; 21(3-4):334-6. PubMed ID: 3500594
[TBL] [Abstract][Full Text] [Related]
17. Modulation by transforming growth factor-beta 1 and interleukin-1 beta of proteoglycan release and chondrodisaccharide composition in porcine articular cartilage.
Zanni M; Tamburro A; Santone I; Rotilio D
Semin Thromb Hemost; 1994; 20(2):159-67. PubMed ID: 7997887
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by cysteine endopeptidase inactivators.
Buttle DJ; Saklatvala J; Barrett AJ
Agents Actions Suppl; 1993; 39():161-5. PubMed ID: 8456627
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-1 and lipopolysaccharides on protein and carbohydrate metabolism in bovine articular cartilage organ cultures.
Morales TI; Hascall VC
Connect Tissue Res; 1989; 19(2-4):255-75. PubMed ID: 2509133
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.
Jeffrey JE; Aspden RM
Arthritis Res Ther; 2007; 9(6):R129. PubMed ID: 18096078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
